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Among the numerous definitions of probiotics, the one with the 
prevailing international scientific consensus is the one adopted in 2002 
by the Joint Committee of the World Health Organization (WHO) 
and the Food and Agriculture Organization (FAO). It was established 
that probiotics are “live microorganisms which when administered in 
adequate amounts confer a health benefit on the host.” (WHO/FAO, 
2002). The majority of the probiotic strains available were isolated and 
characterized from the following species: Lactobacillus casei, L. paraca-
sei, L. rhamnosus, L. acidophilus, L. gasseri, L. johnsonii, L. plantarum, 
L. reuteri, L. crispatus, L. fermentum, Bifidobacterium bifidum, B. 
adolescentis, B. lactis, B. breve, B. infantis, B. longum, Saccharomyces 
boulardii, S. cerevisiae, and Enterococcus faecium. Certain species of the 
genera Bifidobacterium and Lactobacillus, common inhabitants of the 
intestinal microbiota, are traditionally regarded as microorganisms 
beneficial to health, due to the fact they exclusively promote healthy 
effects in their natural niche. Furthermore, some of these strains show 
an adequate tolerance to gastrointestinal barriers and to technological 
parameters applied in the production of food. These facts determine 
that the main commercial strains used for the manufacture of func-
tional foods belong to these genera.
Microbiological control of probiotics in food
The microbiological enumeration of probiotic bacteria in fermented 
foods represents a real challenge to the industry, due to the simulta-
neous presence of probiotics and the acidifying starter bacteria used 
for the fermentation of the food. Even though there is an increas-
ingly marked tendency to apply advanced techniques such as FISH, 
flow cytometry (Ben Amor et al., 2007), and real-time quantitative 
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The intestinal microbiota comprises about 95% of the total cells in 
the human body, and it contains approximately 1011–1012 CFU/g 
of intestinal content. This diffuse “organ” which is not encoded 
in our DNA, is rapidly acquired after birth and is carried with 
us all throughout our lives, experiencing changes in its compo-
sition and its activities which respond not only to endogenous 
factors (e.g., age, stress), but also to exogenous factors (e.g., diet, 
medical treatments). The presence of the intestinal microbiota 
is of essential importance for the development of the mucosal 
immune system and the maintenance of its activity, and also for 
the numerous barrier and biochemical activities that it performs. 
As for the species and strains comprising the intestinal microbi-
ota, there is a wide variability among individuals, depending on 
their age, diet, immunological status, stress factors, and intrinsic 
characteristics of the individual not yet totally known (Isolauri 
et al., 2004). The main genera found in the intestinal microbiota 
include Bacteroides, Eubacterium, Ruminococcus, Clostridium, and 
Bifidobacterium, and as the subdominant microbiota, Escherichia, 
Veillonella, Staphylococcus, Proteus, Streptococcus, and Lactobacillus 
have been reported (Tannock, 2003).
It is possible to classify the components of the intestinal micro-
biota according to the effects they exert on the host’s health: bacteria 
with potentially pathogenic effects, bacteria presenting a mixture of 
pathogenic and beneficial activities, or bacteria with strictly benefi-
cial effects (Gibson et al., 2003). Bifidobacterium and Lactobacillus 
belong to this last group, and are the genera most frequently chosen 
for the isolation and characterization of probiotic bacteria.
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doi: 10.3389/fmicb.2011.00070PCR (Friedrich and Lenke, 2006) for the selective and/or differen-
tial count of probiotic bacteria in fermented milks, routine con-
trols, mainly at an industrial level, are carried out by traditional 
plate counts techniques, which are simple and easy to implement 
in any quality control laboratory. Probiotic bacteria (mainly bifi-
dobacteria and species of the L. casei and L. acidophilus groups; 
Klein et al., 1998) and the starter bacteria used in the elaboration 
of fermented milks (Streptococcus thermophilus and Lactobacillus 
delbrueckii subsp. bulgaricus) or cheese (S. thermophilus, L. helveticus, 
Lactococcus lactis, among other species), are microorganisms phy-
logenetically very closely related and with very similar nutritional 
requirements. Therefore, this factor becomes one of the biggest 
challenges for the differentiation of their colonies on the surface of 
agar plates, since their metabolic responses are very similar. A wide 
variety of culture media has been proposed in the last 20 years for 
the microbiological control of probiotics (Vinderola et al., 2009).
However, the problem of the standardization of the microbio-
logical count of probiotics in food is very far from being solved, 
since it is not possible to call upon a single and official protocol 
valid for all the strains presently used in probiotic foods. This is 
mainly due to the strain-specific response to the different culture 
media. Some aspects to take into account for the development or 
adoption of a culture medium for evaluation of probiotics in food, 
are the following:
•	 Probiotic	 microorganisms,	 mainly	 those	 derived	 from	 the	
genera  Lactobacillus  and  Bifidobacterium,  are  closely  related 
in terms of metabolism to lactic acid starter bacteria. From a 
nutritional point of view, it is difficult to favor the growth of the 
former while trying to inhibit the development of the latter.
•	 In	general,	probiotics	are	added	to	food	as	adjunct	cultures	in	
concentrations of 107–108 CFU/g or ml, without participating 
in the fermentative process and without practically modifying 
their concentration during the elaboration of the product. As 
for starter bacteria, they can reach, after the fermentative pro-
cess, a concentration of between 108 and 109 CFU/g or ml. If 
the development of starter bacteria on the surface of the cul-
ture medium is not adequately inhibited, they may not allow 
the development of or hinder the differential count of probio-
tic bacteria.
•	 In	contrast	to	analyses	for	groups	of	microorganisms	such	as	
coliforms, psychrotrophs, Salmonella, or Escherichia coli, for 
which  there  are  commercially  available  culture  media  and 
standardized protocols for their count, probiotics do not con-
stitute a homogeneous group. Therefore, it has not been possi-
ble so far to design a single culture medium for all the existing 
probiotic strains, suitable at the same time, for all the food 
matrices used as vehicles for probiotics.
•	 Considering	 that	 most	 of	 the	 species	 of	 probiotic	 bacteria	
belong to the Lactobacillus and Bifidobacterium genera and 
many of them have an intestinal origin, it is advisable to use 
biological  or  chemical  inhibitors  (mineral  salts,  bile  salts, 
organic acids, for example) to change a general medium into 
a selective medium for probiotic bacteria. However, it must be 
verified first, by pure culture studies and in the presence of the 
food matrix to be used, that the recovery of viable bacteria is 
as close as possible to 100%.
•	 In	 products	 containing	 more	 than	 one	 probiotic	 species,	
the level of difficulty for carrying out a selective/differential 
count increases, especially if they belong to the same genera. 
It is more likely to be able to adequately distinguish diverse 
species of Lactobacillus than of Bifidobacterium, always in a 
strain-dependent way. So far, it is impossible to differentiate 
probiotic strains belonging to the same species through the 
plate count technique, which constitutes an important limita-
tion when it comes to designing a multi-probiotic food using 
strains  with  different  beneficial  effects.  At  the  same  time, 
the effect of the simultaneous presence of strains must be 
always assessed since beneficial effects are not always additive 
(Timmerman et al., 2004).
•	 When	a	selective	or	differential	culture	medium	is	designed	
or adopted for the count of probiotics in a particular food, it 
is necessary to prove first the individual capacity of each of 
the (probiotic and starter) strains to grow on that medium, 
so as to ensure the complete inhibition of the starter bacteria 
and the total recovery of the probiotic microorganisms. In case 
this is not possible, an adequate differential capacity must be 
guaranteed for an accurate count of each strain. These simple 
steps are very often not determined, hindering then the count 
of probiotics once the food is microbiologically formulated 
and manufactured.
probiotic bacteria: factors influencing their 
functionality
The definition of probiotics recognizes the capacity of live micro-
organisms to exert a beneficial effect on the consumer’s health. 
From the moment they are incorporated into a food, the micro-
biological control of their cell viability is routinely used for the 
monitoring of their functionality. For this reason, the scientific 
criteria (Champagne et al., 1997; Ross et al., 2005) or legislations 
in force (Amagase, 2008; Degnan, 2008; Saxelin, 2008) in some 
countries, require a particular concentration of viable bacteria to 
guarantee the functional quality of the food and to call it, then, 
a probiotic food. However, in the last years and, on the basis of 
different reports, there has been evidence of certain changes in 
functionality, i.e., in the qualitative and quantitative magnitude of 
the beneficial effect of a strain, without levels of viable cells being 
modified. Briefly, changes in the effect induced without changes 
in cell counts: same amount, different effects. In this context, the 
microbiological count would only partially reflect the functional 
capacity of the strain. Therefore, it appears necessary to know, man-
age and control the microbiological variables that may alter the 
functionality of a strain in a particular food matrix, without having 
an impact on the number of viable cells. Throughout the follow-
ing sections, some aspects of the currently available information 
on the factors which may provoke changes in the in vivo response 
of a probiotic, without affecting cell viability, will be presented.
functionality of probiotics and culture production
The first step in the production of a probiotic culture for its large 
scale implementation entails its development in a culture medium 
suitable for biomass production. In this sense, the variables involved 
during the growth of the strain (pH of the medium, type, and 
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et al., 2008) that the immunomodulatory activity (capacity to 
induce IL-12 in cell lines), of a L. lactis strain, changed according 
to the physiological cell status (viable or dead cells) and, at the 
same time, according to the culture medium used for its growth 
(M17 or MRS with added glucose). Likewise, different cell wall 
compositions, at the sugar’s level and in the content of fatty acids 
of cells cultured in both media, were verified, thus determining 
variations in the immunomodulatory activity, and hence in the 
functionality of the strain.
functionality of probiotics and technological processes
High pressure homogenization (HPH) constitutes a novel technol-
ogy that implies the application of high pressures to liquids in order 
to inactivate food pathogens or to modify the rheological proper-
ties of the product, without decreasing the nutritional value of the 
product compared to the application of heat treatments (Paquin, 
1999; Patrignani et al., 2009). The application of mild HPH treat-
ments directly to the cells (up to 500 bars, depending on the strain) 
does not cause cell death but might induce permanent changes of 
functional attributes such as cell surface hydrophobicity and gastric 
resistance. It has been hypothesized that strains presenting a high 
value of cell surface hydrophobicity may have a better capacity to 
interact with immune cells such as macrophages (Ofek and Doyle, 
1994) and may possess a better adhesion to the intestinal epithe-
lium (Kotzamanidis et al., 2010). When a HPH treatment of 500 
bars was applied to a strain of L. paracasei suspended in buffer, its 
gastric resistance (assessed at pH 2.0, 37°C, 0.3% porcine pepsin 
for 90 min) significantly increased. The strain also experienced a 
significant increase in its cell hydrophobicity. However, when the 
HPH treatment was applied to cells suspended in 10% skim milk, 
the effectiveness of the treatment on increasing gastric resistance 
was less significant, probably due to dissipation of the HPH effect 
among milk proteins and cell surface proteins. It is known that the 
exposure to sublethal levels of a stress factor (HPH treatment, in 
this case) may induce resistance to higher levels of the same stress 
factor or to others (gastric acidity, for example), a phenomenon 
called “cross-resistance” (O’Driscoll et al., 1996; Burns et al., 2008).
Another important selection criterion for probiotic bacteria 
has to do with the capacity of adhesion to mucosal surfaces, since 
it allows triggering of some of their functional attributes such as 
immunomodulation. Therefore, adhesion capacity, which is deter-
mined by the superficial structures of cells, may suffer modifica-
tions during the production process of probiotic cells, affecting 
as a result, cell functionality without affecting cell viability. In the 
review by Tuomola et al. (2001) there is a mention of variations in 
the adhesion capacity of commercial probiotic strains during the 
manufacture of probiotic food. As for L. rhamnosus GG, Elo et al. 
(1991) observed mild variations in the levels of adhesion of the 
strain isolated at different points of its production process, after 
analyzing different batches of products. It was also verified that an 
important loss in the adhesion capacity to cell lines occurred when 
the strain was subcultured on a weekly basis for a long period of 
time in MRS broth. For instance, a strain of L. acidophilus isolated 
in two different years from the same commercial product displayed 
a significantly different adhesion capacity between the two isola-
tion times, in both models studied (Caco-2 cells and intestinal 
concentration of carbohydrates, growth phase at harvesting, cell 
physiological state, etc.) may significantly affect both its resistance 
to biological barriers (gastric acidity and bile salts) and its capacity 
to interact with immune cells, thus conditioning its functionality.
Bifidobacterium animalis subsp. lactis INL1, a strain isolated 
from human breast milk (Zacarías et al., 2011), was grown in MRS 
broth in a biofermentor at 37°C. The culture reached the station-
ary phase more rapidly when grown at pH 6.5, in comparison to a 
culture grown at pH 5.0. However, when the strain was subjected to 
a gastric resistance test (pH 2.0, 0.3% pepsin, 37°C, 90 min), a 4 log 
orders of cell death was observed for the culture grown at pH 6.5, 
while the viability loss was negligible during the gastric resistance 
test performed on the culture grown at pH 5.0. Moreover, scanning 
electron microscopy studies performed on the cultures, showed the 
production of extracellular compounds (exopolysaccharide type) 
when the strain was grown at pH 6.5, but not at pH 5.0. These 
compounds might exert an in vivo response different from that 
exerted by the culture grown at pH 5 which displayed no extracel-
lular compounds, a fact that must be still studied.
In relation to the culture medium pH, Saarela et al. (2009) stud-
ied the resistance to gastric acidity and to bile salts of a L. rham-
nosus strain grown at pH 5.0 and 5.8 and further freeze-dried in 
polydextrose and sucrose. The authors observed that the culture 
obtained at pH 5.0 presented a higher resistance to gastric acidity 
than the one grown at pH 5.8, though these differences were only 
observed in the cultures freeze-dried in polydextrose but not in the 
cultures freeze-dried in sucrose as cryoprotectant. In this study, it 
has been unveiled not only the importance of the pH of the culture 
medium used for the production of biomass in gastric resistance 
but also the influence of the cryoprotectant on the viability and 
gastric resistance of the cultures produced. For both pH values 
tested and the two cryoprotectants used, the L. rhamnosus culture 
showed the same retention of viability when preserved at 37°C for 
2 weeks, while gastric acid resistance and resistance to bile salts were 
significantly affected; this demonstrates the utility of these tests as 
monitors for cell functionality.
The growth phase in which the cell harvesting is carried out 
during biomass propagation, is another variable determining cell 
functionality. In our laboratory we observed that the gastric resist-
ance of B. animalis subsp. lactis INL1 strain after 22 h of culture (late 
stationary growth phase) in an anaerobic biofermentor at 37°C, 
presented a gastric resistance significantly higher than the same 
culture grown for 12 h (early stationary growth phase). Sashihara 
et al. (2007) showed that the capacity of a L. gasseri strain to induce 
the synthesis of the pro-inflammatory cytokine IL-12 when co-
cultured with mice splenocytes, depended on the time at which 
the culture was harvested (growth phase); the capacity to induce 
maximum IL-12 production was when the strain reached the late 
stationary growth phase.
The physiological status of a strain is another variable involved in 
its functional properties. So as to exemplify this fact, Lepercq et al. 
(2004) assessed the capacity of a B. animalis strain to deconjugate, 
in vivo, bile salts during its transit through the pig intestine. In 
this case, the activity of bile salts hydrolase turned out to be higher 
when pigs received viable cells instead of heat-inactivated cells. 
Additionally, bile salts hydrolase activity was higher in cells har-
vested in the exponential growth phase compared to cells   harvested 
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that the same probiotic strain can present different behaviors in 
terms of gastric resistance according to the flavor of the fermented 
milk to which is added, stressing the need for adequate viability and 
functionality controls when it comes to developing a new probiotic 
food, even when it may be similar to other products already existing 
in the market, as in the case of fermented milks of different flavors.
Recently, Wang et al. (2009) assessed the resistance of a L. casei 
strain to the gastrointestinal tract (at pH 2.0 and 2.5). L. casei was 
cultured in bovine milk and soy milk and stored at 4°C for 28 days. 
When the resistance of the strain to biological barriers (simulated 
gastric and intestinal juice) was assessed in both products, a protec-
tive effect of the food was observed (in relation to a control culture 
in MRS broth), which was much more significant in the case of 
bovine milk compared to soy milk. As expected, the gastric resist-
ance was higher at pH 2.5 than at pH 2.0. These results stress the 
importance of the food matrix to guarantee not only the survival 
capacity but also the functional properties of probiotic bacteria 
until the moment they are consumed.
functionality of probiotics and biological barriers
As mentioned in the previous sections of this chapter, numerous 
studies have been carried out with the aim of identifying and 
studying the microbiological and technological factors that can 
modify the viability and functionality of probiotic bacteria in food. 
Nevertheless, until now, less attention has been paid to the analysis 
of the physiological factors of the host and the eating habits that 
can affect the functionality of probiotics, apart from the studies 
of resistance to physiological barriers, such as gastric acidity and 
bile salts. One aspect that has been little explored is the effect of 
the simultaneous consumption of different probiotics on the host 
since, a priori, an addition of effects should not be expected. While 
in some cases the addition of multiple strains to a food results in 
additive or potentiating effects, among other things, the relation 
of cost/benefit does not always justify such addition and, may 
even lead to the occurrence of undesirable effects (Timmerman 
et al., 2004). Another important aspect to consider is the period 
of administration of the probiotic. The continuous consumption 
of an immunomodulatory strain could induce mucosal immune 
profiles that can change with time of exposure. This fact might 
then modify the functional properties of the probiotic during 
continuous intake, due to the regulatory capacity of the immune 
system associated to the intestinal mucosa (Coombes and Maloy, 
2007). For example, de Moreno de LeBlanc et al. (2008) showed in 
mice that the continuous long-term administration of a fermented 
milk containing a L. casei probiotic strain, caused a significant 
increase in the number of cells producing IgA in the intestine by 
day 7 of feeding; after the IgA peak a decrease in such response 
was observed when the consumption continued. These results may 
suggest that a cyclical consumption (alternation of administra-
tion/withdrawal cycles) of the probiotic, would induce an average 
response in time, higher than that obtained with a continuous 
consumption. In another study, the short-term administration to 
mice of the cell-free fraction of the fermented milk Kefir, induced 
a proliferation of cells of the innate immunity which produce 
the pro-inflammatory cytokine TNF alpha. On the other hand, 
a longer period of administration resulted in an increase in the 
mucus).Thus, it can be inferred that the factors related to the pro-
duction process of the food matrix used as vehicle for probiotics 
may modify the adhesion of a probiotic strain together with its 
functional attributes with changes not being noticed by quality 
control cell counts.
functionality of probiotics and shelf life
     Foods containing probiotic bacteria act as their vehicles or 
carriers until cells reach the intestinal tract. The food itself may 
have an important influence on the functional attributes of the 
probiotic strain, since it is incorporated in food during its passage 
through the different biological barriers of the gastrointestinal tract. 
In this way, the physicochemical attributes of food (fat and protein 
content, type of proteins, sugars, pH, etc.), certain food ingredients 
(flavoring agents, thickeners, sweeteners, stabilizers, etc.) and added 
functional ingredients (bioactive components) to which probiotic 
bacteria are exposed, may affect their performance in this complex 
matrix, modifying their functionality and efficacy. Consequently, a 
critical point in the formulation of probiotic foods is the optimiza-
tion of all these variables so as to improve the probiotic capacity of 
a designated strain or, at least, so as not to negatively modify it with 
respect to when it was characterized as a pure culture outside a food 
matrix. In particular, dairy products (fermented milks, cheese, ice 
cream, etc.), due to their physicochemical and functional attributes, 
are considered the ideal vehicles for probiotic bacteria. The way in 
which the food matrix influences the functionality of probiotics, 
has been reviewed recently by Ranadheera et al. (2010).
In a recent study conducted by our group, the strain of breast 
milk origin, B. animalis subsp. lactis INL1, was cultured in a biofer-
mentor at pH 5.0, harvested and freeze-dried in 10% lactose as pro-
tectant. The freeze-dried culture was added to different commercial 
liquid food matrices. Inoculated samples were cold-stored to assess 
the influence of the matrix on the gastric resistance of the strain 
along storage. Within 4 weeks at 5°C, there were no changes in the 
levels of viable cells in any of the products studied. However, when 
the products containing the strain were subjected to a simulated 
gastric digestion (pH 2.0, 0.3% pepsin, 37°C, 90 min), there were 
no changes in the resistance to acidity of the banana–apple juice 
and the vanilla flavored milk. However, in the case of the multi-fruit 
juice and the apple–peach puree, a cell death of about 1 logarithmic 
cycle was observed after the gastric digestion, while in the case of 
the apple–banana mix puree and the orange juice, the decay of 
cell viabilities were 2 and 3 log orders, respectively. These results 
show the importance of an adequate selection of a proper food 
matrix for probiotic strains, considering functional variabilities, 
and beyond merely monitoring the levels of viable cells. In relation 
to these results, our group recently showed (Vinderola et al., 2011) 
that different L. casei strains in fermented milks of different flavors, 
which maintained adequate levels of viable cells during refriger-
ated storage, experienced changes in gastric resistance depending 
on the temperature of storage (5 or 12°C, an usual temperature on 
supermarket shelves), during the storage period, and on the flavor 
of the fermented milk. These factors resulted in an increase or 
decrease of gastric resistance, as a result of the possible simultane-
ous presence of sublethal stress factors that might induce gastric 
resistance (such as lactic acidity) as well as the presence of factors 
having inhibitory potential, such as chemical agents used in the 
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inflammatory profile without tissue damage (effective, perhaps, 
against intestinal pathogens) to a regulatory profile (potentially 
effective against intestinal inflammatory diseases). These hypoth-
eses need to be studied in depth and validated in human studies. 
Finally, the in vivo effect of biological barriers, such as bile salts, 
on the functionality of probiotic strains and on their capacity of 
interacting with the intestine, should also be elucidated. In recent 
studies by our group, the adaptation of a non-intestinal strain of L. 
delbrueckii subsp. lactis to bile salts allowed the development of a 
bile-resistant derivative, resistant to physiological concentrations 
of bile salts (0.5% w/v). However, the adaptation to bile diminished 
the autoaggregation capacity of the strain (Figure 1) as well as its 
hydrophobicity and adhesion capacity in vitro and in vivo (Burns 
et al., 2008; 2010). These changes in the cell surface attributes 
induced by bile salts, a powerful natural detergent (Begley et al., 
2005), impacted on cell functionality: the bile-resistant derivative 
was less effective in enhancing the gut mucosal defenses mediated 
by IgA (Burns et al., 2011).
conclusion
The current commercial expansion in the use of probiotic bacteria 
in functional foods must be accompanied by new knowledge and 
exploration of new concepts, together with the study in depth of 
how these bacteria may be influenced by different factors inherent 
to technological processes, the physicochemical environment of 
food, and the gastrointestinal transit. In this sense, the traditional 
concept of control of cell viability as a tool for determining the 
probiotic value of the food must be complemented by an assess-
ment of the functionality of the strain included in a particular 
food. Only in that way will it be possible to ensure that the food 
product is really functional, beyond the functional value that has 
been reported for the probiotic strain alone. In the current chap-
ter, some of the different factors that can modify the functionality 
of a strain during its industrial propagation, its inclusion into a 
technological process for food manufacture and its exposure to 
the product environment, as well as to biological barriers, were 
discussed. Thus, determining the in vivo functionality of food must 
be requested as a procedure that allows commercializing “proven” 
probiotic products, not potential ones.
production of the regulatory cytokine IL-10 (Vinderola et al., 
2006). These changes in the profile of induced cytokines in the 
gut during the long-term administration of bioactive food, would 
indicate possible changes in the functionality of the food depend-
ing on the length of the administration period, shifting from a pro-
Figure 1 | FiTC-labeled (fluorescent) L. delbrueckii subsp. lactis 200 
(above) and its non-autoaggregative bile-resistant derivative  
L. delbrueckii subsp. lactis 200+ (below) in the small intestine lamina 
propria after 30 min of their oral administration to mice. Magnification: 
40×. Arrows indicate lactobacilli cells.
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